Cognitive Research

Selank, the synthetic tuftsin analogue developed in Russia, has attracted growing interest from Western neuropeptide researchers. We examine the GABAergic evidence base, the BDNF connection, and what distinguishes Selank from classical anxiolytics.

Semax, a synthetic ACTH analogue developed at the Russian Academy of Sciences, is increasingly appearing in Western peer-reviewed publications. We review recent neuroprotection and BDNF upregulation data.